The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review
Open accessAbstract
The need to find new therapeutic interventions in patients diagnosed with psychiatric disorders is supported by the data suggesting high rates of relapse, chronic evolution, therapeutic resistance, or lack of adherence and disability. The use of pre-, pro-, or synbiotics as add-ons in the therapeutic management of psychiatric disorders has been explored as a new way to augment the efficacy of psychotropics and to improve the chances for these patients to reach response or remission. This systematic literature review focused on the efficacy and tolerability of psychobiotics in the main categories of psychiatric disorders and it has been conducted through the most important electronic databases and clinical trial registers, using the PRISMA 2020 guidelines. The quality of primary and secondary reports was assessed using the criteria identified by the Academy of Nutrition and Diabetics. Forty-three sources, mostly of moderate and high quality, were reviewed in detail, and data regarding the efficacy and tolerability of psychobiotics was assessed. Studies exploring the effects of psychobiotics in mood disorders, anxiety disorders, schizophrenia spectrum disorders, substance use disorders, eating disorders, attention deficit hyperactivity disorder (ADHD), neurocognitive disorders, and autism spectrum disorders (ASD) were included. The overall tolerability of the interventions assessed was good, but the evidence to support their efficacy in specific psychiatric disorders was mixed. There have been identified data in favor of probiotics for patients with mood disorders, ADHD, and ASD, and also for the association of probiotics and selenium or synbiotics in patients with neurocognitive disorders. In several domains, the research is still in an early phase of development, e.g., in substance use disorders (only three preclinical studies being found) or eating disorders (one review was identified). Although no well-defined clinical recommendation could yet be formulated for a specific product in patients with psychiatric disorders, there is encouraging evidence to support further research, especially if focused on the identification of specific sub-populations that may benefit from this intervention. Several limitations regarding the research in this field should be addressed, i.e., the majority of the finalized trials are of short duration, there is an inherent heterogeneity of the psychiatric disorders, and the diversity of the explored Philae prevents the generalizability of the results from clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some of the bacteria from these and other genera, such as B. helveticus, B. longum, B. animalis, Bacillus subtilis and Enterococcus faecium, have been reported to produce or promote the synthesis of neurotransmitters in the gut18–24, consequently modulating MGBA pathways and affecting behavior25–29.”
From Exploring the impact of probiotics on adult ADHD management through a double-blind RCT (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, probiotic supplementation showed positive effects on ADHD symptoms among children, though much of the evidence comes from open trials rather than randomized controlled trials (RCTs)21.”
From Exploring the impact of probiotics on adult ADHD management through a double-blind RCT (2024) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398 · cited 2×
“The exact mechanisms by which psychobiotics exert their action are incompletely described, but induction of immunomodulatory mechanisms, protective effects against physiological stress, inhibition of pathogens growth, microbiome modulation, and improvement of the barrier function of the colonic epithelium have been ex…”
BackgroundPsychobiotics: A novel class of psychotropic
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287
Probiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2008_097 · Cited by 1,028 · cited 5×
“Within this review, the category of “psychobiotics” includes probiotics (bacteria), prebiotics (nondigestible oligosaccharides), and synbiotics (various combinations of the previous products) (9).”
BackgroundInfluentialThe gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912 · cited 2×
“(66) DBRCT Older adults with MCI (N = 80) Probiotics (Bifid.”
BackgroundGut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885 · cited 3×
“(76) Narrative Children with Probiotics (Lact.”
InfluentialAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767
Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau8317 · Cited by 704 · cited 1×
“The authors of the same study concluded that schizophrenia-like behaviors might be related to hypo-glutamatergic function (72).”
BackgroundGastrointestinal microbiota in children with autism in Slovakia
Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., & Ostatnikova, D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.033 · Cited by 632 · cited 1×
“in feces of medication-free ASD children (N = 10) (59).”
BackgroundKazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534
Research works printed but not linked: 3
- 2012, Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process.
- Berkman, 2013, Grading the Strength of a Body of Evidence when Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods guide for Comparative Effectiveness Reviews.
- Owens, 2022, Grading the Strength of a Body of Evidence When Comparing Medical Interventions. In: Agency for Healthcare Research and Quality. Methods Guide for Comparative Effectiveness Reviews [posted July 2009].
Cited by
Mosquera, F. E. C., Martinez, S. L., & Liscano, Y. (2024) · Nutrients · doi:10.3390/nu16091352 · Cited by 81
“Future research should focus on standardizing psychobiotic formulations and exploring their synergistic effects with conventional antidepressants to fully harness their therapeutic potential [14,24,96].”
BackgroundHuman Gut Microbiota for Diagnosis and Treatment of Depression
Averina, O. V., Poluektova, E. U., Zorkina, Y., Kovtun, A. S., & Даниленко, В. Н. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115782 · Cited by 55
Slykerman, R. F., Davies, N., Vlčková, K., O’Riordan, K. J., Bassett, S. A., Dekker, J., Schellekens, H., Hyland, N. P., Clarke, G. A., & Patterson, E. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70079 · Cited by 47
Probiotics: Bridging the interplay of a healthy gut and psychoneurological well‐being
Meher, A. K., Acharya, B., & Sahu, P. K. (2024) · Food Bioengineering · doi:10.1002/fbe2.12081 · Cited by 40
Wang, L., Tsai, C., Chou, W., Kuo, H., Huang, Y., Lee, S.-Y., Dai, H.-Y., Yang, C.-Y., Li, C.-J., & Yeh, Y. (2024) · Nutrients · doi:10.3390/nu16142260 · Cited by 33
Metadata
- Authors
- Vasiliu, O.
- Affiliations
- Spitalul Universitar de Urgenţă Militar Central Dr. Carol Davila (RO)
- Corresponding author
- Vasiliu, Octavian
- ORCID
- Vasiliu, Octavian
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-02-23
- Volume
- 14
- Pages
- 1074736-1074736
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC9996157
- OpenAlex
- W4321595729
- Cited by
- 42
- References
- 90
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 8
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- psychobiotics, probiotics, synbiotics, mental illness, mood disorders, anxiety disorders, schizophrenia spectrum disorders, substance use disorders, eating disorders, attention deficit hyperactivity disorder, autism spectrum disorder, neurocognitive disorders, selenium, tolerability, efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review. https://app.cochat.ai/papers/10.3389/fpsyt.2023.1074736
- The paper
- Vasiliu, O. (2023). The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1074736
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.